SEC Form 4 research
| Issuer | VERTEX PHARMACEUTICALS INC / MA |
|---|---|
| Tickers | VRTX |
| Reporting owners | 62 |
| Officers and directors | 52 |
| Last public filing | 2026-09-10 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-10 | 2026-09-08 | van Grunsven Jasper | A | 8,682 | $0 | Not reported |
| 2026-09-01 | 2026-08-28 | Ambrose Kristen | A | 5,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.